| Notices |
A prospective randomized trial toward a "blood transfusion"-free hepatectomy.
This is a discussion on A prospective randomized trial toward a "blood transfusion"-free hepatectomy. within the Medical Articles and Abstracts forum; Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood ...
noblood Home 
Resources
Medical Articles and Abstracts
A prospective randomized trial toward a "blood transfusion"-free hepatectomy.
03-26-2006, 08:01 AM
|
||||
|
||||
|
A prospective randomized trial toward a "blood transfusion"-free hepatectomy.
Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.
Ann Surg. 2006; 243(2):173-80 (ISSN: 0003-4932) Wu CC; Ho WM; Cheng SB; Yeh DC; Wen MC; Liu TJ; P'eng FK Department of Surgery, Taichung Veterans General Hospital, and Department of Surgery, Chung-Shan Medical University, Taichung, Taiwan. he@vghtc.gov.tw OBJECTIVE: To examine the feasibility of a real "blood transfusion"-free hepatectomy in a large group of patients with liver tumors. SUMMARY BACKGROUND DATA: Bleeding control and blood transfusion remains problematic in liver resection. A real "blood transfusion"-free hepatectomy in a large group of patients has rarely been reported. The impact of tranexamic acid (TA), an antifibrinolytic agent, on blood transfusion in liver resection is unknown. METHODS: A prospective double-blind randomized trial was performed on elective liver tumor resections. In group A, TA 500 mg was intravenously administered just before operation followed by 250 mg, every 6 hours, for 3 days. In group B, only placebo was given. The patients' background, blood transfusion rates, and early postoperative results in the 2 groups were compared. Factors that influenced blood requirement were analysed. RESULTS: There were 108 hepatectomies in group A and 106 hepatectomies in group B. The patients' backgrounds, operative procedures, and hepatectomy extent did not significantly differ between the 2 groups. Although the differences of the operative morbidity and postoperative stay were not significant, a significantly lower amount of operative blood loss, lower blood transfusion rate, shorter operative time, and lower hospital costs were found in group A patients. No patient in group A received blood transfusion. No hospital mortality occurred in either group. Tumor size and use of TA were independent factors that influenced blood transfusion. CONCLUSIONS: Perioperative parenteral use of TA reduced the amount of operative blood loss and the need for blood transfusion in elective liver tumor resection. A real "blood transfusion"-free hepatectomy may be feasible with the assistance of parenteral TA. PreMedline Identifier: 16432349     
|
 |
| Tags |
| hepatectomy |
«
Previous Thread
|
Next Thread
»
| Currently Active Users Viewing This Thread: 1 (0 members and 1 guests) | |
| Thread Tools | Search this Thread |
| Display Modes | Rate This Thread |
Linear Mode
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Red Cell Transfusion "Trigger": A Review | Jan B. Wade | Medical Articles and Abstracts | 0 | 10-13-2005 07:27 PM |
| "Free" | ernie41 | Public Site Feedback | 0 | 12-22-2003 02:39 PM |
| "Advancements in Blood Conservation" Fairview Hosp. & SABM Conference | bloodlessjoe | Events | 0 | 10-16-2003 03:15 PM |
| Red Cell Transfusion "Trigger": A Review | Jan B. Wade | Medical Articles and Abstracts | 0 | 07-17-2003 03:05 PM |
